Tao Wu - Anyang Tumor Hospital | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

First-line Benmelstobart Plus Anlotinib and Chemotherapy in Advanced or Metastatic/recurrent Esophageal Squamous Cell Carcinoma: a Multi-Center Phase 2 Study

Ning Li,Jin Xia, Xiaohui Gao,Jianwei Zhou, Yonggui Hong, Donghai Cui, Xuesong Zhao,Tao Wu, Yanzhen Guo, Junsheng Wang,Suxia Luo

Signal transduction and targeted therapyno. 1 (2024): 303-303

引用0浏览0WOSNATURE引用

Camrelizumab Plus Apatinib after Progression on Immune Checkpoint Inhibitors in Patients with Advanced Esophageal Squamous Cell Carcinoma (CAP 02 Re-challenge): A Single-Arm Multicenter, Phase II Trial

Xiangrui Meng,Junsheng Wang,Jin Xia,Tao Wu,Zhiquan Luo, Yong-Gui Hong,Ping Lu, Yanzhen Guo, Yinghua Ji,Min Zhang, Liuzhong Yang, Peng Cheng,Wenchang Liang,Zhengzheng Shan, Qingxia Fan,Feng Wang

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 364-364

引用0浏览0引用

Efficacy and Safety of Camrelizumab Plus Apatinib in Patients with Advanced Esophageal Squamous Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors (CAP 02 Re-challenge): a Single-Arm, Phase II Study

Xiangrui Meng,Junsheng Wang,Jin Xia,Tao Wu,Zhiquan Luo,Yonggui Hong,Ping Lu,Yanzhen Guo,Yinghua Ji,Min Zhang,Liuzhong Yang, Peng Cheng,Wenchang Liang,Zhengzheng Shan,Yue Zhou,Mingyue Wang,Taiying Lu, Min Song,Hong Zong,Lijie Song, Wenkang Wang,Lulu Guan, Yanke Li, Jianxiang Xing, Siyuan Xing, Han Wu, Jingwen Chu,Xi Luo,Yao Lu,Dao Xin, Aijia Li, Binghua Jiang, Shenglei Li, Guozhong Jiang,Qingxia Fan, Feng Zhao,Rongrong Zheng, Wenqing Zhu, Zhiguo Hou, Yun Jia,Feng Wang

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

Real-world Effectiveness of Anlotinib Plus PD-1 Inhibitors As Chemo-Free Therapy in Advanced or Metastatic Esophageal Cancer

Junsheng Wang,Yonggui Hong,Tao Wu,Ping Lu,Zhiwei Chang, Wei Liang,Guifang Zhang

Journal of clinical oncologyno. 4_suppl (2023): 310-310

引用0浏览0引用

The Safety and Efficacy of Cadonilimab in Combination with AK117 (Anti-Cd47 Antibody) Plus Chemotherapy As First-Line Treatment for Advanced Gastric (G) or Gastroesophageal Junction (GEJ) Cancer

Qing Xia,Tao Wu,Feng Wang,Shengmian Li,Yu Xia,Baiyong Li,Zhongmin Maxwell Wang,Weifeng Song,Liwei Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Update Results of Anlotinib Combined with TQB2450 (PD-L1 Blockade) As First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma (ESCC): A Single-Arm, Multicenter, Open-Label Phase II Clinical Trial

Xiangrui Meng,Xiuli Yang,Yong-Gui Hong,Zhiye Zhang,Jin Xia,Yunfang Chen,Tao Wu,Zheng-Zheng Shan,Qingxia Fan,Feng Wang

Journal of Clinical Oncologyno. 4_suppl (2023): 377-377

引用0浏览0引用

1531P Update Results of Anlotinib Combined with TQB2450 (PD-L1 Blockade) As First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma (ESCC): A Single-Arm, Multicenter, Open-Label Phase II Clinical Trial

Y-G. Hong,X. Meng, X. Yang,Z-Y. Zhang,J. Xia, Y-F. Chen,T. Wu, Z. Shan,Q. Fan,F. Wang

Annals of Oncology (2023)

引用0浏览0引用

Real-world Effectiveness of Anlotinib in Combination with PD-1 Inhibitors As Second-Line or Later Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Yonggui Hong,Tao Wu,Ping Lu,Zhiwei Chang, Wei Liang,Guifang Zhang,Junsheng Wang

Journal of Clinical Oncologyno. 4_suppl (2022): 320-320

引用3浏览0引用

A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma

Ning Li,Tao Wu,Yong-Gui Hong,Yan-Zhen Guo,Yu-Feng Cheng,Yi-Jie Ma,Liang-Yu Bie,Dong-Hai Cui,Xiao-Hui Gao,Bing-Xu Tan,Bao-Sheng Li,Su-Xia Luo,Jun-Sheng Wang

BMC Medicineno. 1 (2022)

引用0浏览0引用

Update Results of Paclitaxel and Cisplatin in Combination with Anlotinib As First-Line Regimen for Patients with Advanced ESCC: A Multicenter, Single-Arm, Open-Label Phase Ⅱ Clinical Trial

Sheng Wang,Tao Wu,Suxia Luo, Ning Li, Yong-Gui Hong, Yanzhen Guo, Yufeng Cheng,Baosheng Li

Journal of Clinical Oncologyno. 4_suppl (2022): 315-315

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn